45 CFR § 180 compliance
F · 55
This hospital published little of what § 180 requires.
●Machine-readable file published
○Gross / standard charges
○Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
7,831
Insurances with rates
12
CPT / HCPCS codes
6,667
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| J2326 | SPINRAZA (PF) 12 MG/5 ML INTRATHECAL SOLUTION | $333,562 | $333,562 | — | — | 1 |
| Q2043 | PROVENGE 50 MILLION CELL/250 ML INTRAVENOUS SUSPENSION | $289,537 | $289,537 | — | — | 0 |
| J0225 | AMVUTTRA 25 MG/0.5 ML SUBCUTANEOUS SYRINGE | $272,120 | $272,120 | — | — | 0 |
| J2351 | OCREVUS ZUNOVO 920 MG-23,000 UNIT/23 ML SUBCUTANEOUS SOLUTION | $193,199 | $193,199 | — | — | 3 |
| J1823 | UPLIZNA 10 MG/ML INTRAVENOUS SOLUTION | $150,672 | $150,672 | — | — | 3 |
| J9999 | GLIADEL WAFER 7.7 MG IMPLANT | $131,789 | $131,789 | — | — | 7 |
| J8999 | LENVIMA 20 MG/DAY (10 MG X 2) CAPSULE | $119,918 | $119,918 | — | — | 21 |
| 0915T | Insj Perm Ccm-D Sys Pg&Eltrd | $100,994 | $100,994 | — | — | 4 |
| 33264 | Rmvl Pcd W/Rplc Mult Lead | $96,185 | $96,185 | — | — | 13 |
| 63685 | Implant Spinal Neurostim/Receiver | $91,421 | $91,421 | — | — | 6 |
| C2624 | Wireless Pressure Sensor | $90,846 | $90,846 | — | — | 3 |
| J9269 | ELZONRIS 1,000 MCG/ML INTRAVENOUS SOLUTION | $76,965 | $76,965 | — | — | 19 |
| 0636 | KISQALI 400 MG/DAY (200 MG X 2) TABLET | $73,345 | $73,345 | — | — | 7 |
| J8499 | XTANDI 40 MG CAPSULE | $71,548 | $71,548 | — | — | 16 |
| J9334 | VYVGART HYTRULO 1,000 MG-10,000 UNIT/5 ML SUBCUTANEOUS SYRINGE | $70,274 | $70,274 | — | — | 12 |
| 33240 | Insrt Single Chmbr Icd Genratr | $67,339 | $67,339 | — | — | 1 |
| C9741 | Impl Pressure Sensor W/Angio | $67,094 | $67,094 | — | — | 12 |
| J9359 | ZYNLONTA 10 MG INTRAVENOUS SOLUTION | $66,188 | $66,188 | — | — | 1 |
| J1246 | UNITUXIN 3.5 MG/ML INTRAVENOUS SOLUTION | $65,311 | $65,311 | — | — | 5 |
| J2267 | OMVOH 300 MG/15 ML (20 MG/ML) INTRAVENOUS SOLUTION | $61,013 | $61,013 | — | — | 22 |
| 33270 | Insrtn Subq Implnt Defib Systm | $60,155 | $60,155 | — | — | 13 |
| J1459 | PRIVIGEN 10 % INTRAVENOUS SOLUTION | $58,811 | $58,811 | — | — | 14 |
| 33249 | Ins/Rpos Dual Chmb Pcg Lds&Gen | $57,686 | $57,686 | — | — | 5 |
| 33229 | Rmvl Perm Pcmkr W/Rplcmnt Mult Lead | $57,213 | $57,213 | — | — | 3 |
| J2323 | TYSABRI 300 MG/15 ML INTRAVENOUS SOLUTION | $56,472 | $56,472 | — | — | 1 |
| 93591 | Perq Transcath Cls Paravalvr Leak 1 Aortic Valve | $56,208 | $56,208 | — | — | 1 |
| J0717 | CIMZIA STARTER KIT 400 MG/2 ML (200 MG/ML X2) SUBCUTANEOUS SYRINGE KIT | $56,155 | $56,155 | — | — | 19 |
| J2329 | BRIUMVI 25 MG/ML INTRAVENOUS SOLUTION | $55,374 | $55,374 | — | — | 3 |
| J9272 | JEMPERLI 50 MG/ML INTRAVENOUS SOLUTION | $54,483 | $54,483 | — | — | 3 |
| J2327 | SKYRIZI 360 MG/2.4 ML (150 MG/ML) SUBCUTANEOUS WEARABLE INJECTOR | $54,352 | $54,352 | — | — | 20 |
| 37184 | Percutaneous Thrombectomy Prim | $53,870 | $53,870 | — | — | 4 |
| 0238T | Iliac Artery Atherectomy | $53,870 | $53,870 | — | — | 1 |
| J3316 | TRIPTODUR 22.5 MG IM SUSPENSION | $52,364 | $52,364 | — | — | 6 |
| J9022 | TECENTRIQ 1,200 MG/20 ML (60 MG/ML) INTRAVENOUS SOLUTION | $51,457 | $51,457 | — | — | 3 |
| J9024 | TECENTRIQ HYBREZA 1,875 MG-30,000 UNIT/15 ML SUBCUTANEOUS SOLUTION | $51,457 | $51,457 | — | — | 11 |
| J0638 | ILARIS (PF) 150 MG/ML SUBCUTANEOUS SOLUTION | $51,121 | $51,121 | — | — | 1 |
| J1428 | EXONDYS-51 50 MG/ML INTRAVENOUS SOLUTION | $50,880 | $50,880 | — | — | 9 |
| C1882 | DEFIB CBLT XT HF QUAD CRTD MRI 1/EA DTPA2QQ | $50,850 | $50,850 | — | — | 2 |
| J9119 | LIBTAYO 50 MG/ML INTRAVENOUS SOLUTION | $50,326 | $50,326 | — | — | 9 |
| J7198 | FEIBA NF 1,750 UNIT-3,250 UNIT INTRAVENOUS SOLUTION | $50,220 | $50,220 | — | — | 5 |
| C2616 | Y90 Dose | $48,421 | $48,421 | — | — | 1 |
| 93654 | Comp Ep Eval W/Ablation for V-Tach | $44,953 | $44,953 | — | — | 1 |
| J3241 | TEPEZZA 500 MG INTRAVENOUS SOLUTION | $42,685 | $42,685 | — | — | 19 |
| 33262 | Rmvl Pcd W/Rplc Sngl Lead | $42,663 | $42,663 | — | — | 5 |
| J9309 | POLIVY 140 MG INTRAVENOUS SOLUTION | $42,434 | $42,434 | — | — | 1 |
| J9600 | PHOTOFRIN 75 MG INTRAVENOUS SOLUTION | $42,417 | $42,417 | — | — | 7 |
| 93583 | Perq Transcath Septal Reductn Tx | $42,151 | $42,151 | — | — | 1 |
| J3245 | ILUMYA 100 MG/ML SUBCUTANEOUS SYRINGE | $40,952 | $40,952 | — | — | 3 |
| S0088 | GLEEVEC 100 MG TABLET | $40,452 | $40,452 | — | — | 7 |
| J9332 | VYVGART 20 MG/ML INTRAVENOUS SOLUTION | $40,158 | $40,158 | — | — | 5 |
Showing top 50 of 7,831 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.